Top 25 Biotech Companies of 2018

Top 25 Biotech Companies of 2018

PTC Therapeutics to Buy Agilis Biotherapeutics in Deal that Could Exceed $945 Million

  PTC Therapeutics is buying Agilis Biotherapeutics in a deal that has the potential to exceed $945 million with a priority review voucher thrown into the mix as well. PTC Therapeutics, headquartered in South Plainfield, New Jersey, focuses on rare diseases. It currently has two approved therapeutics, Translarna (ataluren), which is marketed in the European Union for ambulatory patients … Συνεχίστε να διαβάζετε PTC Therapeutics to Buy Agilis Biotherapeutics in Deal that Could Exceed $945 Million.